Alert detail

Proposed LCD DL40334: Erythropoiesis Stimulating Agents — NGS

Policy ID: LCD-DL40334Specialty: HematologyAdded: 6/5/2026lcd
High

What changed

New LCD could affect reimbursement for anemia treatments.

Who’s affected: Hematology billing teams

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 14 billing codes. Comment deadline: Dec 15, 2023.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Hematology audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Hematology— the week’s changes and deadlines, delivered to your inbox. No account required.